Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$653K Sell
7,138
-40,027
-85% -$3.6M 0.02% 179
2025
Q3
$3.96M Buy
47,165
+22,165
+89% +$1.72M 0.12% 78
2025
Q2
$1.86M Buy
+25,000
New +$1.33M 0.05% 169
2024
Q4
Sell
-209,570
Closed -$10M 452
2024
Q3
$10M Buy
+209,570
New +$9.14M 0.25% 43
2024
Q1
Sell
-137,300
Closed -$5.92M 532
2023
Q4
$5.92M Buy
137,300
+103,800
+310% +$4.34M 0.19% 66
2023
Q3
$1.33M Sell
33,500
-5,800
-15% -$205K 0.02% 298
2023
Q2
$1.23M Buy
+39,300
New +$1.11M 0.03% 362
2021
Q2
Sell
-225,000
Closed -$3.74M 884
2021
Q1
$3.74M Buy
+225,000
New +$3.46M 0.05% 336
2016
Q3
Sell
-755,514
Closed -$8.29M 426
2016
Q2
$8.29M Buy
+755,514
New +$8.97M 0.18% 143
2015
Q4
Sell
-709,554
Closed -$8.64M 437
2015
Q3
$8.64M Buy
+709,554
New +$9.59M 0.08% 235
2014
Q3
Sell
-437,645
Closed -$8.58M 467
2014
Q2
$8.58M Buy
437,645
+387,645
+775% +$8.09M 0.05% 153
2014
Q1
$1.15M Buy
+50,000
New +$1.11M 0.02% 317

Other funds holding CCJ

UBS O'Connor's CCJ Position: Q4 2025 in Review

UBS O'Connor reduced its Cameco (CCJ) stake by 85% in Q4 2025, selling an estimated $3.6M and leaving 7,138 shares worth $653K. The position accounts for 0.02% of the portfolio, ranked #179.

UBS O'Connor first reported a position in CCJ in Q1 2014 and has held it in 12 quarters since. The position peaked at $10M in Q3 2024. 978 funds tracked by Wall St. Rank hold CCJ as of Q4 2025.

  • UBS O'Connor held 7,138 shares of Cameco worth $653K as of Q4 2025.
  • UBS O'Connor sold 40,027 Cameco shares in Q4 2025, an estimated $3.6M.
  • Cameco made up 0.02% of UBS O'Connor's portfolio in Q4 2025, its #179 holding.
  • UBS O'Connor first reported a position in Cameco in Q1 2014 and has held it in 12 quarters since.
  • UBS O'Connor's Cameco position peaked at $10M in Q3 2024.
  • 978 funds tracked by Wall St. Rank held Cameco as of Q4 2025.

Based on UBS O'Connor's 13F filing for Q4 2025, filed 13 Feb 2026.